Emzotamig
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF) . Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis[1].
Product Specifications
CAS Number
3037572-57-6
UNSPSC
12352100
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
References & Citations
[1]WHO Drug Information, Vol. 39, No. 2, 2025.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BAL2308 1 Each
Phospho-PML Protein (Ser518) Rabbit mAb, 1 pack = 50 µL
Sign In for Pricing
View Details TP306813 20 µg
CAMKIV (CAMK4) (NM_001744) Human Recombinant Protein
Sign In for Pricing
View Details MBS9929149-01 48 Well
Horse Vascular Endothelial Growth Factor (VEGF) ELISA Kit
Sign In for Pricing
View Details MBS9929149-02 96 Well
Horse Vascular Endothelial Growth Factor (VEGF) ELISA Kit
Sign In for Pricing
View Details